Difference between revisions of "Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5 (Q9979)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1016/j.imlet.2017.01.010, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 86-95, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
(5 intermediate revisions by the same user not shown) | |||||||||||||||
Property / PubMed ID | |||||||||||||||
+ | |||||||||||||||
Property / PubMed ID: 28153605 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2017
| ||||||||||||||
Property / Publication Date: 2017 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Published In Name String | |||||||||||||||
+ | Immunol. Lett. | ||||||||||||||
Property / Published In Name String: Immunol. Lett. / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Volume | |||||||||||||||
+ | 183 | ||||||||||||||
Property / Volume: 183 / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / title | |||||||||||||||
+ | CD19 from bench to bedside (English) | ||||||||||||||
Property / title: CD19 from bench to bedside (English) / rank | |||||||||||||||
+ | Normal rank | ||||||||||||||
Property / Page(s) | |||||||||||||||
+ | 86-95 | ||||||||||||||
Property / Page(s): 86-95 / rank | |||||||||||||||
+ | Normal rank |
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Li X, et al. Immunol. Lett. (2017) cited as Ref 716 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Li X
0 references
2017
0 references
Immunol. Lett.
0 references
183
0 references
CD19 from bench to bedside (English)
0 references
86-95
0 references